Skip to content
Acting Auditions – Lifestyle
Author:
Daxor Corporation
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
October 1, 2026
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
September 8, 2026
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
September 1, 2026
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
July 29, 2026
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
July 7, 2026
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
June 2, 2026
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
April 28, 2026
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
April 8, 2026